News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
500,687 Results
Type
Article (28978)
Company Profile (446)
Press Release (471247)
Multimedia
Podcasts (132)
Webinars (32)
Section
Business (154090)
Career Advice (1715)
Deals (22641)
Drug Delivery (139)
Drug Development (69129)
Employer Resources (105)
FDA (11761)
Job Trends (10307)
News (238452)
Policy (19463)
Tag
2027 BioCapital Elite (1)
2027 BioCapital Standard (1)
2027 BioMidwest Elite (2)
2027 BioMidwest Standard (1)
2027 Bio NC Standard (2)
2027 Biotech Bay Elite (3)
2027 Biotech Bay Standard (5)
2027 Biotech Beach Elite (2)
2027 Biotech Beach Standard (3)
2027 Genetown Elite (4)
2027 Genetown Standard (6)
2027 Pharm Country Elite (2)
2027 Pharm Country Premier (1)
2027 Pharm Country Standard (7)
Academia (1817)
Academic (1)
Accelerated approval (56)
ADA (47)
Adcomms (33)
Allergies (182)
Alliances (24967)
ALS (219)
Alzheimer's disease (1602)
Antibody-drug conjugate (ADC) (540)
Approvals (12312)
Artificial intelligence (694)
ASCO (330)
Autoimmune disease (360)
Automation (50)
Bankruptcy (181)
Best Places to Work (8664)
BIO (65)
BIOSECURE Act (17)
Biosimilars (236)
BioSpace Insights (103)
Biotechnology (316)
Bladder cancer (209)
Brain cancer (72)
Breast cancer (816)
Cancer (6237)
Cardiovascular disease (536)
Career advice (1408)
Career pathing (50)
CAR-T (334)
CDC (49)
Celiac Disease (2)
Cell therapy (903)
Cervical cancer (51)
Clinical research (62487)
Collaboration (1992)
Commercialization (5)
Company closure (4)
Compensation (1163)
Complete response letters (78)
COVID-19 (2668)
CRISPR (109)
C-suite (1159)
Cystic fibrosis (155)
Data (8637)
Decentralized trials (3)
Denatured (27)
Depression (167)
Dermatology (102)
Diabetes (651)
Diagnostics (5237)
Digital health (52)
Diversity (6)
Diversity, equity & inclusion (22)
Drug discovery (350)
Drug pricing (156)
Drug shortages (29)
Duchenne muscular dystrophy (299)
Earnings (79197)
Editorial (62)
Employer branding (13)
Employer resources (94)
Events (98005)
Executive appointments (1050)
FDA (15584)
Fibrodysplasia Ossificans Progressiva (10)
Friedreich's ataxia (20)
Frontotemporal dementia (33)
Funding (1762)
Gene editing (234)
Generative AI (65)
Gene therapy (701)
GLP-1 (1227)
Government (3567)
Grass and pollen (6)
Guidances (417)
Healthcare (13754)
Hematology (170)
HIV (97)
Huntington's disease (66)
IgA nephropathy (118)
Immunology and inflammation (319)
Immuno-oncology (108)
Indications (225)
Infectious disease (3010)
Inflammatory bowel disease (199)
Inflation Reduction Act (8)
Influenza (141)
Intellectual property (270)
Interviews (324)
IPO (12502)
IRA (34)
Job creations (1967)
Job search strategy (1170)
JPM (65)
Kidney cancer (25)
Labor market (120)
Layoffs (485)
Leadership (45)
Legal (3417)
Licensing (8)
Liver cancer (92)
Longevity (26)
Lung cancer (858)
Lymphoma (485)
Machine learning (55)
Management (40)
Manufacturing (962)
Marketing (12)
MASH (220)
Medical affairs (1)
Medical device (9582)
Medtech (9749)
Mergers & acquisitions (11358)
Metabolic disorders (1697)
mRNA (282)
Multiple sclerosis (199)
NASH (21)
Neurodegenerative disease (463)
Neuropsychiatric disorders (113)
Neuroscience (3221)
Neurotech (1)
NextGen: Class of 2026 (4209)
Non-profit (2812)
Now hiring (71)
Obesity (810)
Opinion (256)
Ovarian cancer (227)
Pain (239)
Pancreatic cancer (341)
Parkinson's disease (391)
Partnered (33)
Patents (509)
Patient recruitment (789)
Peanut (59)
People (36939)
Pharmaceutical (79)
Pharmacy benefit managers (14)
Phase 1 (18564)
Phase 2 (29487)
Phase 3 (20365)
Pipeline (10065)
Policy (240)
Postmarket research (1794)
Preclinical (6948)
Press Release (72)
Prostate cancer (339)
Psychedelics (65)
Radiopharmaceuticals (300)
Rare diseases (1177)
Real estate (2756)
Recruiting (45)
Regulatory (17904)
Reports (56)
Research institute (1827)
Resumes & cover letters (306)
Rett syndrome (49)
RNA editing (26)
RSV (89)
Schizophrenia (177)
Series A (309)
Series B (231)
Service/supplier (14)
Sickle cell disease (119)
Special edition (29)
Spinal muscular atrophy (164)
Sponsored (36)
Startups (2356)
State (2)
Stomach cancer (18)
Supply chain (113)
Tariffs (67)
The Weekly (103)
Vaccines (1157)
Venture capital (120)
Weight loss (547)
Women's health (115)
Worklife (21)
Date
Today (119)
Last 7 days (692)
Last 30 days (2158)
Last 365 days (27950)
2026 (17364)
2025 (27747)
2024 (29892)
2023 (31709)
2022 (38979)
2021 (41554)
2020 (39378)
2019 (31238)
2018 (24220)
2017 (22869)
2016 (21117)
2015 (25598)
2014 (19385)
2013 (14760)
2012 (15805)
2011 (16656)
2010 (14639)
Location
Africa (553)
Alabama (84)
Alaska (5)
Arizona (252)
Arkansas (11)
Asia (28472)
Australia (5044)
California (13225)
Canada (3368)
China (1458)
Colorado (532)
Connecticut (615)
Delaware (416)
Europe (66779)
Florida (1860)
Georgia (418)
Hawaii (5)
Idaho (41)
Illinois (1020)
India (87)
Indiana (588)
Iowa (24)
Japan (587)
Kansas (98)
Kentucky (48)
Louisiana (57)
Maine (60)
Maryland (1535)
Massachusetts (9929)
Michigan (293)
Minnesota (666)
Mississippi (6)
Missouri (133)
Montana (21)
Nebraska (27)
Nevada (138)
New Hampshire (67)
New Jersey (3569)
New Mexico (31)
New York (3503)
North Carolina (1596)
North Dakota (9)
Northern California (6631)
Ohio (382)
Oklahoma (17)
Oregon (41)
Pennsylvania (2502)
Puerto Rico (27)
Rhode Island (37)
South America (743)
South Carolina (40)
South Dakota (1)
Southern California (5275)
Tennessee (189)
Texas (2100)
United States (46289)
Utah (338)
Vermont (2)
Virginia (294)
Washington D.C. (70)
Washington State (1094)
West Virginia (2)
Wisconsin (149)
500,687 Results for "m2gen".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
M2GEN Rebrands to Aster Insights
M2GEN today announced it is rebranding, changing the company’s name to Aster Insights™.
April 14, 2023
·
3 min read
ORIEN Researchers to Present Key Findings Utilizing M2GEN’s Avatar Data at AACR Annual Meeting
M2GEN , an oncology-focused health informatics solutions company, today announced its participation as a presenter, exhibitor, and research partner at the American Association for Cancer Research (AACR) Annual Meeting April 14-19, 2023.
April 7, 2023
·
5 min read
Business
M2GEN Appoints Kyle Dunn as Chief Revenue Officer to Deliver Next Phase of Company’s Growth
M2GEN, a bioinformatics company accelerating discoveries in oncology research through industry-leading data and analytics, today announced the appointment of Kyle Dunn to its executive team as Chief Revenue Officer.
October 17, 2022
·
2 min read
Business
M2GEN Expands World-Class Executive Leadership Team; Appoints Melissa Honour, MPH, as Chief Product Officer
M2GEN today announced the appointment of Melissa Honour, MPH, to its executive leadership team as Chief Product Officer.
July 12, 2022
·
4 min read
Business
M2GEN Announces Collaboration with Microsoft to Advance Bioinformatics Solutions for Oncology
M2GEN will utilize Microsoft technologies to power its data and analytics platform.
December 9, 2021
·
3 min read
Business
M2GEN and Discovery Life Sciences Enter into Agreement to Leverage M2GEN’s New Oncology-Focused Bioinformatics Support Services
M2GEN announced today that it has entered into an agreement with Discovery Life Sciences, a global leader in biospecimen solutions, genomic, cell, and immunohistochemistry (IHC) services, to provide M2GEN’s recently launched oncology-focused bioinformatics support services.
September 25, 2020
·
3 min read
Business
CD&R, Merck GHI, and McKesson Ventures Invest in Innovative Oncology Data and Informatics Company M2GEN
M2GEN today announced a significant new investment by Clayton, Dubilier & Rice (“CD&R”) funds, the Merck Global Health Innovation Fund (“Merck GHI”), and McKesson Ventures to recapitalize M2GEN, a leading oncology data and informatics platform focused on transforming cancer care, in partnership with its existing shareholders
March 17, 2021
·
6 min read
M2GEN® Announces the Launch of its Oncology-Focused Bioinformatics Support Services
M2GEN announced today the launch of its oncology-focused Bioinformatics Support Services. Leveraging the results and knowledge gained from the ORIEN Avatar® Program, an extensive, unique and ever-growing oncology clinico-genomics dataset, the M2GEN Bioinformatics team provides bioinformatics support services adhering to best-in-class standards.
August 25, 2020
·
3 min read
Business
M2GEN® Appoints Chris Tunnell Vice President of Global Sales
M2GEN, an oncology-focused health informatics solutions company with the mission to help patients access the best treatment options by leveraging their clinical and molecular data to accelerate the discovery, development and delivery of tailored and more personalized therapies, announced today the appointment of Chris Tunnell as Vice Pres
May 7, 2020
·
3 min read
Business
M2Gen® Appoints Dr. Helge Bastian President and Chief Executive Officer
Bastian succeeds M2Gen Executive Chair William S. Dalton, M.D., Ph.D., who has served as interim CEO since September 2018.
August 14, 2019
·
5 min read
1 of 50,069
Next
